Cytokines and systemic biomarkers are related to the size of abdominal aortic aneurysms
D Flondell-Sité, B Lindblad, T Kölbel, A Gottsäter - Cytokine, 2009 - Elsevier
Objective: The etiology of abdominal aortic aneurysm (AAA) includes atherosclerotic,
inflammatory, immunological and coagulatory mechanisms. The aim of this study was to …
inflammatory, immunological and coagulatory mechanisms. The aim of this study was to …
Cytokines as plasma markers of abdominal aortic aneurysm
V Třeška, O Topolčan, L Pecen - 2000 - degruyter.com
The pathogenesis of abdominal aortic aneurysms (AAA) is a complex process in which
atherosclerosis and inflammation play a leading role. Cytokines are important mediators of …
atherosclerosis and inflammation play a leading role. Cytokines are important mediators of …
Circulating biomarkers and abdominal aortic aneurysm size
FA Hellenthal, B Pulinx, JTJ Rob, JAW Teijink… - Journal of Surgical …, 2012 - Elsevier
BACKGROUND: Abdominal aortic aneurysm (AAA) is a degenerative disease of the
abdominal aorta leading to progressive dilatation, intra-luminal thrombus (ILT) formation …
abdominal aorta leading to progressive dilatation, intra-luminal thrombus (ILT) formation …
Inflammatory markers associated with abdominal aortic aneurysm
S Lindberg, M Zarrouk, J Holst, A Gottsäter - European Cytokine Network, 2016 - Springer
Purpose Inflammation with leukocytic infiltration, degradation of extracellular matrix (ECM),
and depletion of vascular smooth muscle cells (VSMC) are pathological hallmarks of …
and depletion of vascular smooth muscle cells (VSMC) are pathological hallmarks of …
Plasma cytokine levels and risks of abdominal aortic aneurysms: A population-based prospective cohort study
M Liao, CL Liu, BJ Lv, JY Zhang, L Cheng… - Annals of …, 2015 - Taylor & Francis
Background. Abdominal aortic aneurysm (AAA) is characterized by inflammatory cell
accumulation in AAA lesions that produce inflammatory cytokines and advance its …
accumulation in AAA lesions that produce inflammatory cytokines and advance its …
Cytokines in abdominal aortic aneurysm: master regulators with clinical application
OA Puchenkova, VO Soldatov, AE Belykh… - Biomarker …, 2022 - journals.sagepub.com
Abdominal aortic aneurysm (AAA) is a potentially life-threatening disorder with a mostly
asymptomatic course where the abdominal aorta is weakened and bulged. Cytokines play …
asymptomatic course where the abdominal aorta is weakened and bulged. Cytokines play …
Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm
PW Stather, DA Sidloff, N Dattani… - Journal of British …, 2014 - academic.oup.com
Background Many studies have investigated the systemic and local expression of
biomarkers in patients with abdominal aortic aneurysm (AAA). The natural history of AAA …
biomarkers in patients with abdominal aortic aneurysm (AAA). The natural history of AAA …
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm
J Juvonen, HM Surcel, J Satta, AM Teppo… - … , and vascular biology, 1997 - Am Heart Assoc
The basic feature in the pathogenesis of abdominal aortic aneurysm (AAA) is the
degradation of extracellular matrix components. This process is induced partly by cytokines …
degradation of extracellular matrix components. This process is induced partly by cytokines …
Proinflammatory and anti-inflammatory cytokine balance in patients with abdominal aortic aneurysm and the impact of aneurysm size
J Wallinder, D Bergqvist… - Vascular and …, 2009 - journals.sagepub.com
Abdominal aortic aneurysm is a common condition with high mortality due to rupture;
however, the condition also is associated with nonaneurysmal cardiovascular mortality. A …
however, the condition also is associated with nonaneurysmal cardiovascular mortality. A …
Pathophysiology of abdominal aortic aneurysm: Biomarkers and novel therapeutic targets
M Torres-Fonseca, M Galan, D Martinez-Lopez… - Clínica e Investigación …, 2019 - Elsevier
Abdominal aortic aneurysm (AAA) is a vascular pathology with a high rate of morbidity and
mortality and a prevalence that, in men over 65 years, can reach around 8%. In this disease …
mortality and a prevalence that, in men over 65 years, can reach around 8%. In this disease …